Skip to main content

MYLAN SM 50 MYLAN SM 50 Pill - yellow capsule/oblong, 22mm

Pill with imprint MYLAN SM 50 MYLAN SM 50 is Yellow, Capsule/Oblong and has been identified as Sunitinib Malate 50 mg. It is supplied by Mylan Pharmaceuticals Inc.

Sunitinib is used in the treatment of Gastrointestinal Stromal Tumor; Renal Cell Carcinoma; Pancreatic Cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sunitinib 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN SM 50 MYLAN SM 50

Sunitinib malate 50 mg MYLAN SM 50 MYLAN SM 50

Sunitinib Malate

Imprint
MYLAN SM 50 MYLAN SM 50
Strength
50 mg
Color
Yellow
Size
22.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Multikinase inhibitors, VEGF/VEGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-6680
Inactive Ingredients
silicon dioxide, croscarmellose sodium, gelatin, magnesium stearate, mannitol, sodium lauryl sulfate, titanium dioxide, ferric oxide yellow, ammonia, ferrosoferric oxide, propylene glycol, shellac

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.